Rossby Financial’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Rossby Financial's BIIB Position: Q3 2026 in Review
Rossby Financial reduced its Biogen (BIIB) stake by 2% in Q3 2026, selling an estimated $424 and leaving 96 shares worth $21.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1221.
Rossby Financial first reported a position in BIIB in Q4 2025 and has held it in 4 quarters since. 1,056 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.
- Rossby Financial held 96 shares of Biogen worth $21.7K as of Q3 2026.
- Rossby Financial sold 2 Biogen shares in Q3 2026, an estimated $424.
- Biogen made up ﹤0.01% of Rossby Financial's portfolio in Q3 2026, its #1221 holding.
- Rossby Financial first reported a position in Biogen in Q4 2025 and has held it in 4 quarters since.
- 1,056 funds tracked by Wall St. Rank held Biogen as of Q3 2026.
Based on Rossby Financial's 13F filing for Q3 2026, filed 5 Nov 2026.